[E4] English Session 4
epilepsy2

[E-014] Efficacy and safety of everolimus in Japanese patients with refractory seizures associated with TSC

^○Masashi Mizuguchi¹, Hiroko Ikeda², Kuriko Kagitani-shimono³, Harumi Yoshinaga⁴, Yasuhiro Suzuki⁵, Makoto Aoki⁶, Chikako Shinpo⁶, Masataka Yonemura⁶, Masaya Kubota⁷ (1.Department of Developmental Medical Sciences, The University of Tokyo, Tokyo, Japan, 2.Department of Pediatrics, Shizuoka Institute of Epilepsy and Neurological Disorders, NHO, Shizuoka, Japan, 3.Department of Pediatrics, Graduate School of Medicine, Osaka University, Osaka, Japan, 4.Department of Child Neurology, Okayama University Hospital, Okayama, Japan, 5.Department of Pediatric Neurology, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan, 6.Oncology Development and Medical Affaris, Novartis pharma K.K., Tokyo, Japan, 7.Division of Neurology, National Center for Child Health and Development, Tokyo, Japan)